eNauka - pregled
Pregled prema Projekat AbbVie, Inc
Prikaz rezultata 1 do 2 od 2
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2022 | Association Between Clinically Meaningful Improvements in Patient-Reported Outcomes and Stringent Measures of Disease Activity in Patients with Psoriatic Arthritis Treated with Upadacitinib Versus Placebo Or Adalimumab: Results from a Phase 3 Trial | Gossec, Laure; Damjanov, Nemanja S; Tsuji, Shigeyoshi; Lertratanakul, Apinya; Lippe, Ralph; Patel, Janki; Zueger, Patrick; De, Vlam K | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2019 | Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis: Results at 48 Weeks from the Select-Monotherapy Study | Smolen, Josef S; Emery, Paul; Rigby, William; Tanaka, Yoshiya; Ignacio, Vargas Juan; Damjanov, Nemanja S; Jain, Manish; Sui, Yunxia; Enejosa, Jeffrey; Pangan, Aileen L;
Camp, Heidi S; Cohen, Stanley B;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |